New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer – MD Anderson Cancer Center

MD Anderson Cancer Center shared on LinkedIn:

”At the 2024 American Association for Cancer Research Annual Meeting, our Samer Srour and Michael Migden presented results from two clinical trials highlighting novel immunotherapy advances, including a new allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer.
Learn about the findings.”

Source: MD Anderson Cancer Center/LinkedIn